Treatments for Schizophrenia

Follow the links below to find information about treatments for schizophrenia.

Updated December 2007

Printer friendly page

Related HealthInsite Topics

Systematic Reviews of Treatments for Schizophrenia
HealthInsite Topic Page
Links to systematic reviews of the evidence for treatments for schizophrenia.

18 Resources Found
Results 1 to 18 displayed.

Title:   Schizophrenia: improving recovery
Publisher:   myDr
Description:   A national study documents the devastating disability of schizophrenia experienced by patients.
Date:   Feb 2001

Title:   Schizophrenia medicines
Publisher:   myDr
Description:   Medicines for schizophrenia can be broadly classified into 'older' and 'newer' antipsychotics.
Date:   May 2005

Title:   Schizophrenia and young people
Publisher:   Multicultural Health Communication Service (NSW)
Description:   Discusses causes and symptoms of schizophrenia and its effects on young people.
Date:   May 1996

Title:   Schizophrenia
Publisher:   Child and Youth Health - CYH (South Australia)
Description:   Schizophrenia interferes with the way a person thinks and acts. In the long term it may change a person's personality.
Date:   Feb 2008

Title:   Schizophrenia
Publisher:   Child and Youth Health - CYH (South Australia)
Description:   People with schizophrenia have times when they become severely disturbed in their behaviour, thoughts and feelings (psychosis).
Date:   Feb 2008

Title:   Summary Australian and New Zealand clinical practice guideline for the treatment of schizophrenia
Publisher:   Royal Australian and New Zealand College of Psychiatrists
Description:   Provides a summary of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Clinical Practice Guideline for the Management of Schizophrenia.
Date:   Jun 2003

Title:   Schizoaffective disorder
Publisher:   Better Health Channel
Description:   Schizoaffective disorder is a combination of two mental illnesses - schizophrenia and a mood disorder. Schizoaffective disorder is classified into two subtypes: schizoaffective bipolar type and schizoaffective depressive type. Mental health professionals currently believe that schizoaffective disorder is a kind of schizophrenia.
Date:   Jan 2007

Title:   Diabetes and antipsychotic drugs (Comments for consumers)
Publisher:   Australian Prescriber
Description:   People with schizophrenia have an increased chance of developing diabetes. The risk of diabetes can also be increased by some of the medicines used to treat schizophrenia.
Date:   Oct 2004

Title:   New antipsychotic medications
Publisher:   Australian Prescriber
Description:   Schizophrenia is a mental disorder which affects about 3 people in every thousand. Drugs called antipsychotics are used to treat schizophrenia. Newer treatments aim to reduce the number of adverse effects.
Date:   Jan 1999

Title:   Media release. New PBS listings for April 2008
Publisher:   Australian Government Department of Health and Ageing
Description:   Cancer patients, children with Attention Deficit Hyperactivity Disorder, people suffering from schizophrenia, stroke patients and the Indigenous community will benefit from changes to the Pharmaceutical Benefits Scheme from 1 April 2008.
Date:   Apr 2008

Title:   Diabetes and antipsychotic drugs
Publisher:   Australian Prescriber
Description:   There is an increased risk of diabetes in patients with schizophrenia and this risk is elevated by some antipsychotic medications. The risk is greater with the atypical drugs clozapine and olanzapine and the low potency conventional antipsychotics than with risperidone or high potency conventional drugs.
Date:   Oct 2004

Title:   Mental illness and violence
Publisher:   Better Health Channel
Description:   People who are receiving treatment for a mental illness are no more violent or dangerous than anyone else. There is a weak association between violence and mental illness, when alcohol or drug misuse is involved. Early treatment of mental illness is the key to preventing violence.
Date:   Sep 2007

Title:   Antipsychotic drugs in pregnancy and breastfeeding
Publisher:   Australian Prescriber
Description:   There are limited data on the safety of antipsychotic drugs in pregnancy and breastfeeding. Reports of congenital abnormalities in the babies of women taking typical antipsychotics are uncommon, although chlorpromazine may cause symptoms in the neonate. No increased risk with atypical antipsychotics has yet emerged.
Date:   Dec 2007

Title:   Are atypical antipsychotics advantageous? - the case against
Publisher:   Australian Prescriber
Description:   This article argues that conventional antipsychotic drugs are just as effective as atypical antipsychotics.
Date:   Dec 2004

Title:   Are atypical antipsychotics advantageous? - the case for
Publisher:   Australian Prescriber
Description:   This article argues that the atypical antipsychotic drugs are preferred because of their better adverse effect profile and efficacy advantages in some patients.
Date:   Dec 2004

Title:   The new antidepressants - clinical applications
Publisher:   Australian Prescriber
Description:   The new antidepressants are generally as efficacious as the older tricyclic antidepressants and monoamine oxidase inhibitors, but have safety advantages.

Title:   New antipsychotic medications
Publisher:   Australian Prescriber
Description:   The introduction of clozapine, risperidone and olanzapine has improved the outcomes for patients with psychoses. The reduced extrapyramidal adverse effects of the new antipsychotic medications, compared with standard antipsychotics, make them the drugs of choice for patients with a recent onset of psychosis.
Date:   Jan 1999

Title:   Smoking and mental illness
Publisher:   SANE Australia
Description:   People with mental illness, like many others, often smoke because they have learned to use it as a way of dealing with feelings such as boredom or stress.
Date:   Jan 2005
Results 1 to 18 displayed.
  • Other Related Topics: